Rhythm Pharmaceuticals In...
(RYTM)
undefined
undefined%
At close: undefined
55.24
-0.07%
After-hours Dec 13, 2024, 04:15 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -184.68M | -181.12M | -69.61M | -134.00M | -140.73M | -74.06M | -33.71M | -25.87M | -11.07M | -6.49M | -21.43M | -18.13M |
| Depreciation & Amortization | 1.76M | 1.67M | 1.16M | 690.00K | 834.00K | 442.00K | 223.00K | 144.00K | - | - | 20.00K | 17.00K |
| Stock-Based Compensation | 32.55M | 19.83M | 20.80M | 17.45M | 11.88M | 6.39M | 2.28M | 1.17M | 298.00K | 66.00K | 127.00K | - |
| Other Working Capital | 4.38M | -13.26M | -15.15M | -16.40M | -5.44M | -6.29M | -1.99M | 863.00K | -1.46M | -801.00K | 2.78M | -1.38M |
| Other Non-Cash Items | 9.40M | 5.91M | -250.00K | -234.00K | 203.00K | 4.51M | -76.00K | 11.00K | 1.42M | -280.00K | 255.00K | 82.00K |
| Deferred Income Tax | - | - | -100.00M | - | - | - | 1.86M | - | - | - | - | - |
| Change in Working Capital | 4.81M | -19.72M | 1.90M | -5.89M | 5.07M | 667.00K | -39.00K | 1.33M | 2.38M | -801.00K | 2.00M | 201.00K |
| Operating Cash Flow | -136.16M | -173.43M | -146.00M | -121.98M | -122.75M | -62.06M | -29.46M | -23.22M | -6.98M | -7.51M | -19.16M | -17.83M |
| Capital Expenditures | -47.00K | -4.28M | -5.43M | -214.00K | -3.38M | -722.00K | -133.00K | -1.06M | -17.00K | - | - | - |
| Acquisitions | - | 4.00M | 100.00M | -158.75M | 24.59M | - | - | - | - | - | - | - |
| Purchase of Investments | -354.92M | -251.94M | -524.97M | -86.87M | -295.82M | -248.59M | -126.92M | -15.22M | - | - | -28.74M | -8.80M |
| Sales Maturities Of Investments | 354.97M | 284.25M | 361.25M | 245.61M | 271.24M | 162.17M | 17.01M | 11.17M | - | - | 23.61M | 3.53M |
| Other Investing Acitivies | -5.67M | -4.00M | 7.00M | 158.75M | -24.59M | -86.43M | -109.91M | -4.05M | - | - | - | - |
| Investing Cash Flow | -5.67M | 28.03M | -62.16M | 158.53M | -27.97M | -87.15M | -110.04M | -5.11M | -17.00K | - | -5.13M | -5.27M |
| Debt Repayment | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 25.49M | 82.72M | 4.75M | 2.01M | 2.12M | 1.81M | 41.54M | - | 41.71M | 7.42M | 19.88M | 22.40M |
| Financial Cash Flow | 74.37M | 213.83M | 166.48M | 2.01M | 163.47M | 164.69M | 167.20M | - | 41.71M | 7.42M | 19.88M | 22.44M |
| Net Cash Flow | -67.60M | 68.43M | -41.68M | 38.56M | 12.75M | 15.48M | 27.70M | -28.33M | 34.72M | -89.00K | -4.40M | -660.00K |
| Free Cash Flow | -136.20M | -177.71M | -151.44M | -122.19M | -126.14M | -62.78M | -29.59M | -24.28M | -6.99M | -7.51M | -19.16M | -17.83M |